Le modèle centré sur le patient qui semble s’imposer dans la formation médicale, met l’accent sur l’importance de prendre en compte la vision du patient, de l’amener à participer au processus de soins et souligne le rôle que joue la communication...
Un temps réservé aux groupes les plus importants, aux directeurs de la communication les plus zélés, l’écoute des conversations en ligne et la surveillance des publications sur le web est devenue une...
Regular FirstWord Pharma PLUS readers may not be surprised to hear that a leading pharmaceutical equity analyst – International Strategy & Investment's Mark Schoenebaum – has suggested that Gilead Sciences' hepatitis C treatment Sovaldi could generate global sales of $5 billion in 2014, its first year on the market.
The monoclonal anti-CD20 antibody rituximab, combined with chemotherapeutic agents, has been shown to prolong overall survival in physically fit patients with previously untreated chronic lymphocytic leukemia (CLL) but not in those with coexisting conditions. We investigated the benefit of the type 2, glycoengineered antibody obinutuzumab (also known as GA101) as compared with that of rituximab, each combined with chlorambucil, in patients with previously untreated CLL and coexisting conditions.
The BMJ no longer publishes research funded by tobacco companies. Richard Smith and Peter Gøtzsche say that research funded by drug companies is also flawed and published to encourage sales, but Trish Groves says that the industries are fundamentally different and that moves are afoot to increase integrity
A new analysis of the multiple myeloma Intergroupe Francophone du Myelome (IFM) 2005-02 trial showed that lenalidomide (Revlimid) maintenance prolongs progression-free survival after stem cell transplantation, but does not improve overall survival.1 This is possibly attributed to the shorter survival time after first disease progression than is observed in patients receiving placebo, the investigators suggested.
43% of rheumatologists report they use four digital devices on a regular basis (desktop, laptop, tablet, phone). 32% report they use three devices and 18% report they use two devices.
Only 7% are only using one device
Among devices used for professional purposes, rheumatologists report they use their smartphone the most often (41%) and their smartphone has the greatest influence (30%) on their practice and clinical decision-making.
Once upon a time, opinion leaders in all aspects of life were people that had spent considerable time on a subject, through academic study or hands-on experience, or both. Such individuals had the authority that came from having witnessed all possible outcomes of different theories and behaviors but, as Albert Einstein said: “the permanence of an expert in a subject area is the greatest obstacle to the advancement of the subject”. Revolutions in thinking were slow to occur.
Dans son dernier bulletin « Vigilances » daté de janvier 2014, l’Agence nationale de sécurité du médicament et des produits de santé met à disposition des professionels de santé des tableaux téléchargeables afin d’aider les prescripteurs à s’approprier l’usage des nouveaux anticoagulants
Two stories in today's Wall Street Journal caught my attention. The first article reported that Eli Lilly will lay off 30% of its U.S. salesforce (see here). Why? Generics, of course, was mentioned first. But if you read on, you will find this tidbit:
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.